Usp1 modulates hepatocellular carcinoma progression via the hippo/taz axis

HIGHLIGHTS

• who: Dongyi Liu from the (UNIVERSITY) have published the paper: USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis, in the Journal: (JOURNAL) of 22/Nov/2022
• what: The study proposed a regulatory link between USP1 and the Hippo/TAZ axis and a promising target for treating HCC. The research showed that USP1 depletion specifically Cell Death and Disease 14:264 increased K11-linked ubiquitination (Fig 6C). The authors propose that pharmaceutically targeting USP1 function or inhibiting USP1 expression may be effective in suppressing Hippo/TAZ-driven hepatocellular carcinoma.
• how: The small . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.